Inhibition of angiogenesis by interleukin-12 is mediated by the interferon-inducible protein 10

Blood

Volumn 87, Issue 9, 1996, Pages 3877-3882

  Sgadari, Cecilia ^a   Angiolillo, Anne L ^b   Tosato, Giovanna ^b  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; INTERLEUKIN 12; NEUTRALIZING ANTIBODY; PROTEIN;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; FEMALE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS;

EID: 0029922177     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.9.3877.bloodjournal8793877     Document Type: Article

References (55)

1. Kobayashi M, Fitz L, Ryan M, Hewick RM, Clark SC, Chan S, Loudon R, Sherman F, Perussia B, Trinchieri G: Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes. J Exp Med 170:827, 1989
2. Stern AS, Podlaski FJ, Hulmes JD, Pan YE, Quinn PM, Wolitzky AG, Familletti PC, Stremlo DL, Truitt T, Chizzonite R, Gately MK: Purification to homogeneity and partial characterization of cytotoxic lymphocyte maturation factor from human B-lymphoblastoid cells. Proc Natl Acad Sci USA 87:6808, 1990
3. Gubler U, Chua AO, Schoenhaut DS, Dwyer CM, McComas W, Motyka R, Nabavi N, Wolitzky AG, Quinn PM, Familletti PC, Gately MK. Coexpression of two distinct genes is required to generate secreted bioactive cytotoxic lymphocyte maturation factor. Proc Natl Acad Sci USA 88:4143, 1991
4. Wolf SF, Temple PA, Kobayashi M, Young D, Dicig M, Lowe L, Dzialo R, Fitz L, Ferenz C, Hewick RM, Kelleher K, Herrmann SH, Clark SC, Azzoni L, Chan SH, Trinchieri G, Perussia B: Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells. J Immunol 146:3074, 1991
5. Schoenhaut DS, Chua AO, Wolitzky AG, Quinn PM, Dwyer CM, McComas W, Familletti PC, Gately MK, Gubler U: Cloning and expression of murine IL-12. J Immunol 148:3433, 1992
6. D'Andrea A, Rengaraju M, Valiante NM, Chehimi J, Kubin M, Aste M, Chan SH, Kobayashi M, Young D, Nickbarg E: Production of natural killer cell stimulatory factor (interleukin 12) by peripheral blood mononuclear cells. J Exp Med 176:1387, 1992
7. Gately MK, Desai BB, Wolitzky AG, Quinn PM, Dwyer CM, Podlaski FJ, Familletti PC, Sinigaglia F, Chizzonite R, Gubler U: Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). J Immunol 147:874, 1991
8. Zeh HJ, Hurd S, Storkus WJ, Lotze MT: Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: Implications for the immunotherapy of cancer. J Immunother 14:155, 1993
9. Chan SH, Kobayashi M, Santoli D, Perussia B, Trinchieri G: Mechanisms of IFN-gamma induction by natural killer cell stimulatory factor (NKSF/IL-12): Role of transcription and mRNA stability in the synergistic interaction between NKSF and IL-2. J Immunol 148:92, 1992
10. Gately MK, Warner RR, Honasoge S, Carvajal DM, Faherty DA, Connaughton SE, Anderson TD, Sarmiento U, Hubbard BR: Administration of recombinant IL-12 to normal mice enhances cytolytic lymphocyte activity and induces production of IFN-γ in vivo. Int Immunol 6:157, 1994
11. Manetti R, Parronchi P, Giudizi MG, Piccinni MP, Maggi E, Trinchieri G, Romagnani S: Natural killer cell stimulatory (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells. J Exp Med 177:1199, 1993
12. + T cells through IL-12 produced by Listeria-induced macrophages. Science 260:547, 1993
13. + T cells to enhance priming for IFN-γ production and diminishes IL-4 inhibition of such priming. Proc Natl Acad Sci USA 90:10188, 1993
14. Nastala CL, Edington HD, McKinney TG, Tahara H, Nalesnik MA, Brunda MJ, Gately MK, Wolf SF, Schreiber RD, Storkus WJ, Lotze MT: Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J Immunol 153:1697, 1994
15. Brunda MJ, Luistro L, Warrier RR, Wright RB, Hubbard BR, Murphy M, Wolf SF, Gately MK: Antitumor and antimetastatic activity of interleukin 12 against murine tumors. J Exp Med 178:1223, 1993
16. Heinzel FP, Schoenhaut DS, Rerko RM, Rosser LE, Gately MK: Recombinant interleukin 12 cures mice infected with Leishmania major J Exp Med 177:1505, 1993
17. Locksley RM. Interleukin 12 in host defense against microbial pathogens. Proc Natl Acad Sci USA 90:5879, 1993
18. Tripp CS, Wolf SF, Unanue ER: Interleukin 12 and tumor necrosis factor α are costimulators of interferon γ production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci USA 90:3725, 1993
19. Wynn TA, Jankovic D, Hieny S, Cheever AW, Sher A: Endogenous IL-12 regulates granuloma formation induced by eggs of schistosoma mansoni and exogenous IL-12 both inhibits and prophylactically immunizes against egg pathology. J Exp Med 179:1551, 1994
20. Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A: Interleukin 12 is required for the T-lymphocyte-independent induction of interferon-γ by an intracellular parasite and induces resistante in T-cell deficient hosts. Proc Natl Acad Sci USA 90:6115, 1993
21. Wolf SF, Sieburth D, Sypek J: Interleukin 12: A key modulator of immune function. Stem Cells 12:154, 1994
22. Voest EE, Kenyon BM, O'Reilly MS, Truitt G, D'Amato RJ, Folkman J: Inhibition of angiogenesis in vivo by interleukin 12. J Natl Cancer Inst 87:557, 1995
23. Kerbel RS, Hawley RG: Interleukin 12: Newest member of the antiangiogenesis club. J Natl Cancer Inst 87:557, 1995
24. Friesel R, Komoriya A, Maciag T: Inhibition of endothelial cell proliferation by gamma-interferon. J Cell Biol 104:689, 1987
25. Sato N, Nariuchi H, Tsuruoka H, Nishihara T, Beitz JC, Calabresi P, Frackleton AR: Actions of TNF and IFN-gamma on angiogenesis in vitro. J Invest Dermatol 95:85S, 1990 (suppl 6)
26. Saegusa Y, Ziff M, Welkovich L, Cavender D: Effect of inflammatory cytokines on human endothelial cell proliferation. J Cell Physiol 142:488, 1990
27. Saiki I, Sato K, Yoo YC, Murata J, Yoneda J, Kiso M, Hasegawa A, Azuma I: Inhibition of tumor-induced angiogenesis by the administration of recombinant interteron-gamma followed by a synthetic lipid-A subunit analogue (GLA-60). Int J Cancer 51:641, 1992
28. Kobayashi S, Nagaura T, Kimura I, Kimura M: Interferon-gamma-activated macrophages enhance angiogenesis from endothelial cells of rat aorta. Immunopharmacology 27:23, 1994
29. Good DJ, Polverini P, Rastinejad F, LeBeau MM, Lemons RS, Frazier WA, Bouck NP: A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci USA 87:6624, 1990
30. Maione T, Gray G, Petro J, Hunt A, Donner A, Bauer S, Carson H, Sharpe R: Inhibition of angiogenesis by recombinant human platelet factor-4 and related peptides. Science 247:77, 1990
31. Muller G, Behrens J, Nussbaumer U, Bohlen P, Birchmeier W: Inhibitory action of transforming growth factor β on endothelial cells. Proc Natl Acad Sci USA 84:5600, 1987
32. Cozzolino F, Torcia M, Aldinucci D, Ziehe M, Almerigogna F, Bani D, Stern D: Interleukin 1 is an autocrine regulator of human endothelial cell growth. Proc Natl Acad Sci USA 87:6487, 1990
33. Taylor S, Folkman J: Protamine is an inhibitor of angiogenesis. Nature 297:307, 1982
34. Ingber D, Fujita T, Kishimoto S, Sudo K, Kanamaru T, Brem H, Folkman J: Synthetic analogues of fumagillin that inhibit angiogenesis and suppress tumor growth. Nature 348:555, 1990
35. Takigawa M, Nishida Y, Suzuki F, Kishi J, Yamashita K, Hayakawa T: Induction of angiogenesis in chick yolk-sac membrane by polyamines and its inhibition by tissue inhibitors of metalloproteinases (TIMP and TIMP-2). Biochem Biophys Res Commun 171:1264, 1990
36. O'Reilly M, Holmgren L, Sing Y, Chen C, Rosenthal R, Moses M, Lane W, Cao Y, Sige H, Folkman J: Angiostatin, a novel angiogenesis inhibitor that mediates the suppression of metastases by Lewis lung carcinoma. Cell 79:185, 1994
37. Lunardi-Iskandar Y, Bryant JL, Zeman RA, Lam VH, Samaniego F, Besnier JM, Hermans P, Thierry AR, Gill P, Gallo RC: Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature 375:64, 1995
38. Angiolillo AL, Sgadari C, Taub DD, Liao F, Farber JM, Maheshwari S, Kleinman HK, Reaman GH, Tosato G: Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J Exp Med 182:155, 1995
39. Strieter RM, Kunkel SL, Arenberg DA, Burdick MD, Polverini PJ: Interferon γ-inducible protein 10 (IP10), a member of the C-X-C chemokine family, is an inhibitor of angiogenesis. Biochem Biophys Res Commun 210:51, 1995
40. Kleinman H, McGarvey J, Hassell J, Star V, Cannon F, Laurie G, Martin GR: Basement membrane complexes with biological activity. Biochemistry 25:312, 1986
41. Vanguri P, Farber JM: IFN and virus-inducible expression of an immediate early gene, crg-2/IP-10, and a delayed gene, I-Aα, in astrocytes and microglia J Immunol 152:1411, 1994
42. Rosenberg AS, Finbloom DS, Maniero TG, Van Der Meide PH, Singer A: Specific prolongation of MHC class 11 disparate skin allografts by in vivo administration of anti-IFN-γ monoclonal antibody. J Immunol 144:4648, 1990
43. Burd PR, Thompson WC, Max EE, Mills FC: Activated mast cells produce interleukin 13. J Exp Med 181:1373, 1995
44. Passaniti A, Taylor R, Pili R, Guo Y, Long P, Haney J, Pauly R, Grant D, Martin G: A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin and fibroblast growth factor. Methods Lab Invest 67:519, 1992
45. Luster AD, Ravetch JV: Biochemical characterization of a γ interferon-inducible cytokine (IP-10). J Exp Med 166:1084, 1987
46. Vanguri P, Farber J: Identification of CRG-2 an interferon-inducible mRNA predicted to encode a murine monokine. J Biol Chem 265:15049, 1990
47. Oppenheim JJ, Zachariae COC, Mukaida N, Matsushima K: Properties of the novel proinflammatory supergene "intercrine" cytokine family. Annu Rev Immunol 9:617, 1991
48. Luster AD, Greenberg SM, Leder P: The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J Exp Med 182:219, 1995
49. Sarris AH, Broxmeyer HE, Wirthmueller U, Karasavvas N, Cooper S, Lu L, Krueger J, Ravetch JV: Human interferon-inducible protein 10: Expression and purification of recombinant protein demonstrate inhibition of early human hematopotetic progenitors. J Exp Med 178:1127, 1993
50. Taub DD, Loyd AR, Conlon K, Wang JM, Ortaldo JR, Harada A, Matsushima K, Kelvin DJ, Oppenheim JJ: Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothelial cells. J Exp Med 177:1809, 1993
51. Luster AD, Leder P: IP-10, a -C-X-C-chemokine, elicits a potent thymus-dependnet antitumor response in vivo. J Exp Med 178:1057, 1993
52. Liao F, Rabin RL, Yannelli JR, Koniaris LG, Vanguri P, Farber JM: The human Mig Chemokine: Biochemical and functional characterization J Exp Med 182:1301, 1995
53. Luster AD, Unkeless J, Ravetch J: γ-Interferon transcriptionally regulates an early-response gene containing homology to platelet proteins. Nature 315:672, 1985
54. Jackson JD, Yan Y, Brunda MJ, Kelsey LS, Talmadge JE: Interleukin-12 enhances peripheral hematopoiesis in vivo. Blood 85:2371, 1995
55. Folkman J: The role of angiogenesis in tumor growth. Cancer Biol 3:65, 1992